PulmoLife™ COPD Monitor
Because early detection and treatment of COPD, especially in smokers, can positively influence the disease course, it is important to screen those patients at risk. PulmoLife is the ideal tool to use as a quick check of lung function to highlight early signs of disease.
PulmoLife is suitable for FEV1 testing programs, identification of early signs of COPD in smokers over 35, and encouraging susceptible smokers to quit.
Features & Benefits
- Quick and easy-to-use
- Large visual display and step-by-step screening instructions
- Accurate and easy-to-clean turbine
- Provides a clearly visible display of FEV1 and FEV1% - FEV1 is strongly recommended as the measurement of choice in COPD screening and the percent of predicted values can be used to help determine the level of severity of disease.
- The monitor calculates Lung Age to show smokers the damage they have caused to their lungs, especially beneficial for patient education and encouragement.
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
The Latest News From Vyaire
CHICAGO – May 14, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, announced today that Vyaire has been selected by the European Commission as a supplier of priority medical equipment to help address the COVID-19 pandemic.Read More
CHICAGO and WICHITA, KAN.,– May 4, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, together with Spirit AeroSystems [NYSE: SPR], announced today a new manufacturing and supply collaboration to build critical care ventiRead More